Clinton Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-10,351
Closed -$1.69M 542
2017
Q4
$1.69M Buy
+10,351
New +$1.86M 0.15% 200
2016
Q4
Sell
-17,390
Closed -$4M 1071
2016
Q3
$4M Sell
17,390
-31,083
-64% -$7.6M 0.19% 156
2016
Q2
$11.2M Buy
+48,473
New +$11.2M 0.49% 36

Other funds holding AGN

Clinton Group's AGN Position: Q1 2018 in Review

Clinton Group sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 10,351 shares — an estimated $1.69M sold.

Clinton Group first reported a position in AGN in Q2 2016 and held it in 3 quarters. The position peaked at $11.2M in Q2 2016. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Clinton Group reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Clinton Group sold 10,351 Allergan plc shares in Q1 2018, an estimated $1.69M.
  • Clinton Group first reported a position in Allergan plc in Q2 2016 and held it in 3 quarters.
  • Clinton Group's Allergan plc position peaked at $11.2M in Q2 2016.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Clinton Group's 13F filing for Q1 2018, filed 14 May 2018.